热尼斯坦减轻了甘诱导的偏头痛:调节氧化介导的血管扩张和氧化应激
Sarika Chaudhary1, Lovedeep Singh2, Manjot Kaur3
1University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, 140413, India.
Metabolic brain disease
|May 25, 2024
概括
植物性雌激素Genistein可以通过减少氧化 (NO) 介导的血管扩张和氧化应激来缓解偏头痛. 这项研究探讨了基因斯坦因.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 偏头痛是一种普遍的神经疾病,其特点是使人虚弱的头痛,影响15-20%的人口.
- 雌激素的波动与偏头痛触发因素有关,植物性雌激素如热尼斯坦可能具有治疗潜力.
- 氧化 (NO) 在偏头痛病理生理学中起着至关重要的作用,调解血管扩张和疼痛感知.
研究的目的:
- 调查基尼斯坦对实验诱导的偏头痛的潜在保护作用.
- 为了阐明氧化 (NO) 在基尼斯坦抗偏头痛作用中的作用.
主要方法:
- 偏头痛模型在小鼠中被诱导使用酸甘油 (NTG) 给药.
- 基因斯坦 (20 mg/kg) 和L-NAME (一种氧化合成酶抑制剂) 进行了治疗.
- 进行了行为测试 (疼痛,焦虑,光恐惧症) 和生化分析 (氧化应激标志物,TNF-α).
主要成果:
- 酸甘油诱导了显著的头痛,类似焦虑的行为,氧化压力和TNF-α水平的升高.
- 热尼斯坦治疗显著降低了NTG诱导的疼痛,焦虑以及炎症和氧化应激的生化标志物.
- L-NAME部分逆转了基因斯坦的保护作用,表明没有参与.
结论:
- 热尼斯坦显示出显著的抗偏头痛作用,减轻疼痛,焦虑和氧化应激.
- 热尼斯坦的保护机制可能涉及氧化物介导的血管扩张和氧化应激的抑制.
- 热尼斯坦代表了对偏头痛管理的潜在治疗药物.
相关概念视频
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Antianginal Drugs: Nitrates and β-Blockers
575
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
575
Antihypertensive Drugs: Vasodilators
505
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
505
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159


